PURE - PURE Bioscience, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/3/2020
Current
4/30/20201/31/202010/31/20197/31/20194/30/2019
Market Cap (intraday) 5
153.80M53.44M35.40M20.00M24.94M34.46M
Enterprise Value 3
151.77M53.19M34.49M19.60M24.60M34.13M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
39.2028.2219.239.5412.8017.21
Price/Book (mrq)
46.6868.8626.1616.8121.1330.85
Enterprise Value/Revenue 3
42.3823.9598.8449.2540.13109.38
Enterprise Value/EBITDA 6
-78.36102.49-55.91-18.30-14.21-39.50

Trading Information

Stock Price History

Beta (5Y Monthly) 0.12
52-Week Change 3470.97%
S&P500 52-Week Change 35.18%
52 Week High 32.0500
52 Week Low 30.2000
50-Day Moving Average 31.4709
200-Day Moving Average 30.7353

Share Statistics

Avg Vol (3 month) 3198.12k
Avg Vol (10 day) 3113.38k
Shares Outstanding 586.89M
Float 57.5M
% Held by Insiders 142.70%
% Held by Institutions 10.02%
Shares Short (Apr 29, 2013) 4222.97k
Short Ratio (Apr 29, 2013) 42.56
Short % of Float (Apr 29, 2013) 41.86%
Short % of Shares Outstanding (Apr 29, 2013) 41.82%
Shares Short (prior month Mar 27, 2013) 4254.8k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3Aug 14, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2019
Most Recent Quarter (mrq)Apr 29, 2020

Profitability

Profit Margin -59.68%
Operating Margin (ttm)-59.79%

Management Effectiveness

Return on Assets (ttm)-41.20%
Return on Equity (ttm)-95.51%

Income Statement

Revenue (ttm)3.58M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)611.90%
Gross Profit (ttm)1.18M
EBITDA -1.95M
Net Income Avi to Common (ttm)-2.14M
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.02M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.68
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-1.82M
Levered Free Cash Flow (ttm)-1.05M